A PHARMACEUTICAL COMBINATION COMPRISING A COX-2 INHIBITOR AND A iNOS INHIBITOR
申请人:AstraZeneca AB
公开号:EP1100505A1
公开(公告)日:2001-05-23
US6248745B1
申请人:——
公开号:US6248745B1
公开(公告)日:2001-06-19
[EN] A PHARMACEUTICAL COMBINATION COMPRISING A COX-2 INHIBITOR AND A iNOS INHIBITOR<br/>[FR] COMPOSITION PHARMACEUTIQUE CONTENANT UN INHIBITEUR DE COX-2 ET UN INHIBITEUR DE iNOS
申请人:ASTRA PHARMA PROD
公开号:WO2000000200A1
公开(公告)日:2000-01-06
The invention relates to the co-administration of an inhibitor of induced nitric oxyde synthase of formula (I) and an inhibitor of cyclooxygenase-2 for the treatment of inflammation and inflammatory disorders.
Three-Component Domino Synthesis of 2-Arylquinazoline-4-amines in One Pot by Activating an sp3 C-H Bond in a Nonmetal Catalytic Oxidation System
作者:Li-Yan Zeng、Wen-Bin Yi、Chun Cai
DOI:10.1002/ejoc.201101315
日期:2012.1
The nonmetalcatalyticoxidationsystem I2/tert-butyl hydroperoxide (TBHP) has been unprecedentedly applied to a three-componentdomino reaction and simultaneously a simple and efficient protocol has been developed to newly synthesize 2-aryl-N-substitutied quinazoline-4-amines in onepot from isatoic anhydride, aromatic amine, and another amine containing methylene adjacent to nitrogen. This protocol